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ABSTRACT
Background: Côte d'Ivoire had no type 3 wild poliovirus (WPV3) outbreak since 1999. In 2011, the country was re-
infected by WPV3. The objective of this study is to explore the reasons behind the occurrence of WPV3 outbreak in 
Côte d'Ivoire in 2011.
Method: Data on WPV3 cases were obtained from specific investigation records during the outbreak investigation. 
Data on AFP cases was obtained from AFP routine investigation forms. Information on polio immunization was 
extracted from National EPI databases and documents. Univariate analyses were done to summarize characteristics of  
AFP and WPV3 cases. Bivariate and multivariable analyses were done to compare polio cases to non-polio AFP cases. 
Finally, the proportion of  non-vaccinated children in routine immunization from 2006 to 2010 was calculated. 
Results: In the Côte d'Ivoire outbreak, from January to July 2011, 36 WPV3 cases were notified. The median age was 
two years old (interquartile range two to four years old). Among these cases, 29 had received less than three polio 
vaccine doses. The majority of  WPV3 cases were living in precarious socio-economic conditions. 
Regarding vaccination status of  AFP cases, the polio cases had a statistically significant higher risk to have less than 
three doses of  polio vaccine compared to non-polio cases, OR: 16.9 [95% CI: 2.3 – 125.0]. More than 27% of  the 
children of  less than one year old who were expected to be vaccinated in the country were not vaccinated from 2006 
to 2010. 
Conclusion: Despite the limitations, this study shows that a country that has interrupted polio transmission for 
one type of  poliovirus can still be at high risk for polio outbreaks of  this same type following an importation. 
This can occur when routine immunization coverage is low, polio supplementary immunization activities are done 
with only the poliovirus vaccine against the circulating poliovirus, people live in precarious socio-economic 
conditions and AFP surveillance is poorly performed. Côte d'Ivoire experienced this outbreak as many of  these 
conditions occurred together.  
INTRODUCTION
In 1988, the World Health Assembly by a special 
resolution asked the member states of  the World 
Health Organization (WHO) to fight for the 
eradication of  polio. The majority of  states in the 
world have joined this initiative. The Global Polio 
eradication Initiative (GPEI) uses vaccination as key 
intervention. Since the start of  the polio eradication 
initiatives in 1988, polio cases have decreased by 
more than 99%, from an estimated 350,000 cases in 
1988 to 407 reported cases in 2013. The reduction is 
the result of  the global effort to eradicate the disease. 
In 2013, polio remained endemic in only three 
countries (Afghanistan, Nigeria and Pakistan), down 
1from more than 125 countries in 1988.  However, as 
long as a single child remains infected, children in all 
countries are at risk of  contracting polio. According 
to World Health Organization (WHO), failure to 
eradicate polio from these last remaining 
strongholds could result within 10 years in as many 
1as 200,000 new cases every year, all over the world.
In 2012, the World Health Assembly of  the World 
Health Organization (WHO) declared the 
completion of  polio eradication a programmatic 
1emergency for global health.
Côte d'Ivoire faces problems to maintain 
interruption of  polio transmission. In this country, 
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after several years without wild poliovirus 
transmission, wild poliovirus type 1 (WPV1) was 
reintroduced in December 2008. The circulation 
continued until 2009 and 26 cases of  WPV1 
infection were notified. In response to this epidemic, 
10 national immunization days (NIDs) using the 
monovalent type 1 vaccine were conducted in 2009 
and 2010. The circulation of  WPV1 stopped in 
August 2009. Wild poliovirus type 3 (WPV3) which 
transmission had been interrupted since 1999, but 
an outbreak of  wild poliovirus type 3 occurred in 
2011. 
The aim of  this study is to investigate and 
understand the reasons behind the 2011 WPV3 
outbreak in Côte d'Ivoire and the response to this 
outbreak. 
METHODS
Study type, sources of  information and data 
collection 
We conducted a retrospective study to explore the 
reasons behind the WPV3 outbreak in Côte d'Ivoire 
in 2011. 
The description of  the WPV3 cases was based on 
data collected during the process of  epidemic 
investigation. For each confirmed case of  WPV, a 
field epidemiological investigation was conducted to 
identify factors that may explain the occurrence of  
the infection. Epidemiological surveillance officers 
registered these data using an investigation form. 
The description of  the AFP cases and analysis to 
compare polio cases to non-polio AFP cases was 
based on data collected in 2011 by epidemiological 
surveillance officers using the routine AFP 
surveil lance forms. Information on polio 
immunization was extracted from national EPI 
databases and documents. 
Operational definitions and variables 
 An acute flaccid paralysis (AFP) is defined as:
- Any case of  AFP in a child <15 years of  age;
OR
- Any case of  paralytic illness (regardless of
age) in which a clinician suspects polio
- A case of  wild poliovirus (WPV) is defined
as a person with AFP for whom a stool
specimen tested positive for WPV by
virology in an accredited WHO laboratory.
- Vaccination status, during the wild
poliovirus type 3 cases investigation, only
those who could give evidence with a
vaccination card were considered to be
vaccinated in routine immunization.
Laboratory tests and AFP cases classification
Laboratory tests were performed by the Pasteur 
Institute of  Côte d'Ivoire, a WHO accredited 
laboratory. 
Study populations
The study population for WPV characteristics 
analysis comprises all WPV3 cases in Côte d'Ivoire in 
2011. Characteristics analysis for AFP cases is about 
all cases of  AFP in 2010 and 2011. Immunization 
coverage and respon  to epidemic refer to the se
whole population of  Côte d'Ivoire. 
Data analysis and presentation
The information collected on the investigation 
records was entered, cleaned and analyzed using the 
EPI Info software 3.5.4.
- Univariate analysis was performed to
summarize the characteristics of  WPV3
cases.
- Univariate analysis was performed to
summarize the characteristics of  AFP cases.
- A bivariate analysis was conducted to access
differences between polio cases and non-
polio AFP cases. We reported crude odds
ratios (OR) and 95% confidence intervals.
- A multivariate analysis (logistic regression)
was performed to build an explanatory
model to look for confounding, interaction
and linear trends. We reported adjusted odds
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ratios (OR) and 95% confidence intervals.
- A calculation was performed to get the
number of  children not vaccinated during 5
years from routine immunization coverage
and the target population of  children under
one year old from 2006 to 2010.
Ethics 
The data were collected in routine activities and 
during an outbreak investigation. We did not get 
approval of  an ethic committee. Before data 
collection, we obtained children parents' oral 
consent. 
RESULTS 
1.1     Description of  cases with wild poliovirus 
type 3 infection 
During the 2011 outbreak in Cote d'Ivoire, 511 cases 
of  AFP were notified and among them, 36 cases 
were confirmed as wild poliovirus cases. The median 
age of  the WPV cases was two years old 
(interquartile range: two to four years old); 35 out of  
36 children were less than five years old (table 1). The 
ratio of  boys to girls was 1.6:1. More than half  of  the 
cases (20 out of  36) came from foreign families and 
the majority of  these polio cases (27 out of  36) lived 
in villages or camps. The housing conditions of  35 
out of  36 cases were classified as precarious. Most of  
these families (30 out of  36) did not have access to 
tap water, while more than half  of  the cases (19 out 
of  36) had no latrines (table 5). Finally all these polio 
cases come from different household.
Regarding vaccination status, only three of  36 polio 
cases (8%) were vaccinated at polio zero; polio zero 
is a polio vaccine dose administered at birth. Among 
the children with poliomyelitis 11 out of  36 received 
the first dose of  oral polio vaccine (OPV1). Also 
nine of  poliomyelitis cases were vaccinated on the 
second polio vaccine dose (OPV2). 
Finally, seven polio cases among 36 cases (19%) were 
vaccinated with the third dose of  oral polio vaccine 
(OPV3). Among the 36 polio cases, 24 cases had not 
received any dose of  polio vaccine in routing 
immunization.
The first notified case of  polio occurred in week 4 of  
the year 2011 and was notified in week 5. The 
second, third and fourth cases occurred four to five 
weeks later. Then, from week 11 to week 17, no cases 
were notified. The peaks of  the epidemic were in 
May and June 2011. The last case occurred in week 
30.
Figure 1: Evolution of  Wild Poliovirus type 3 cases in Côte d'Ivoire in 2011
Table I: Socio demographic characteristic of WPV3 in Côte d'Ivoire 
in 2011 (N= 36)
Factors Categories Number Frequency %
 Age 2* [2;4]*
Male 22 61Sex
Female 14 39
Ivorian 16 44Nationality 
Foreigner 20 56
Town 9  25Place of residence 
Village or camp 27 75
Precarious housing 35 97Type of housing 
Modern housing 1  3
Running water 6  17Source of water 
Non running 30 83
Latrine available 17 47Latrine 
No Latrine available 19 53
Appropriate 1  4
Elimination of waste
 water (N=25)
Non appropriate 24 96
* Median age in years; the interquartile range is given between brackets.
Table II: Vaccination status of WPV3 cases in Côte d’Ivoire in 2011 
N=36
Factors Number Frequency (%)
Immunized Polio 0 3 8
Immunized Polio 1 11 32
Immunized Polio 2 9 25
Immunized Polio 3 7 19
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The most affected districts were the districts 
Duekoué and Soubré. Among the 101 districts 23 
(22.7%) notified at least one polio case. Seven 
regions out of  19 regions in the country did not 
notified polio cases. The eastern part of  the country 
was the less affected area during this epidemic.  
Characteristics of  AFP cases in Côte d'Ivoire in 2010 
and 2011, 
Characteristic of  AFP surveillance in 2010 and 
2011
Concerning socio demographic characteristic of  
AFP cases, the median age of  AFP cases in 2011 was 
2.6 years (interquartile range: 1.6 to 5 years).
The sex ratio boy to girls was 1.4:1. The majority of  
AFP cases were boys (58.1%). A small proportion of  
AFP cases were hospitalized for their paralysis 
(17.2%).
Concerning the number of  polio vaccine doses 
received by the AFP cases, the median number of  
vaccine doses received was two (interquartile range: 
zero to four doses). A high proportion of  AFP cases 
(71.2%) had less than three doses of  polio vaccine. 
Comparison of  characteristics of  Polio cases to 
non-polio cases 
Table 5 offers summary information of  this 
comparison. On bivariate analysis, polio was 
significantly associated with age, hospitalization, and 
vaccination status. 94.4% of  polio cases were under 
5 years old compared to 75.2% of  the non-polio 
AFP cases (OR 5.6; 95% CI 1.3 - 23.7). 30.6% of  
polio cases had been hospitalized compared to 
16.2% of  the non-polio AFP cases (OR 2.3; 95% CI 
1.1 - 4.8). 30 of  36 polio cases (83.3%) had received 
less than three doses of  polio vaccine compared to 
47.6% among the rest of  the AFP population. This 
association between polio and vaccination status was 
strong and significant: OR 15.5; 95% CI 2.1; 114.5. 
No significant differences were found between polio 
and non-polio cases in the following characteristics: 
male sex (OR 0.9; 95% CI 0.4 – 1.8), presence of  
fever (OR 0.9 [95% CI: 0.4 – 1.8]), sudden 
progression of  paralysis (OR 0.5; 95% CI 0.2 – 1.2]), 
and symmetry of  limb paralysis (OR 1.2; 95% CI 0.5 
– 2.6).
The three major signs of  polio (sudden onset of  
asymmetrical paralysis and fever) were present 
together in 19.4% of  the polio cases and in 15.6% of  
the non-polio cases. This difference was not 
statistically significant (OR 1.3; 95% CI: 0.5 – 3.1)
In multivariate analysis
The association between polio vaccine doses and 
wild poliovirus type 3 cases remained highly 
significant when controlling for age. Age was found 
to be an associated factor which improves the 
association between polio vaccine doses and WPV3. 
Interaction term and linear trends were tested by 
using chi square for Likelihood ratio test, interaction 
terms such as (age group and sex) and linear trends 
(age) were found to not fit the data significantly 
better than  those without the interaction terms and 
linear trends (Model with age and vaccine polio 
dose/WPV3). 
Thus, after adjustment for age, polio cases were 
  
Table III: Socio demographic characteristics of AFP cases in Côte 















*Median age in years; the interquartile range is given between brackets.





Total polio doses 511 2 [0;4]*
Total polio doses < 3 
doses 511 364 71.2
*Median polio doses; the interquartile range is given between brackets.
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more likely to have less than three polio vaccine 
doses compared to non-polio cases (adjusted OR 
16.9; 95% CI: 2.3 - 125.0).Finally, polio cases were 
also more likely to be under 5 years old than non-
polio cases, after adjustment for vaccination status 
(adjusted OR 6.3; 95% CI: 1.5-26.9).
1.2 Polio immunization coverage and number of  
children at risk of  WPV3 before the onset of  the 
epidemic in 2011
OPV3 vaccination coverage was below 80%, except in 
2010. In the year 2006, this coverage in the country 
started to decrease from 76% to reach 58% in 2008. This 
coverage increased afterwards to reach 81% in 2010 and 
then decreased in 2011 to reach 58%.  
We determined the number of  unvaccinated children 
against polio from 2006 to 2010. In total there was an 
accumulation of  807,930 unvaccinated children (27%) 
during the five years.
Before the epidemic in 2011, there were several polio 
NIDs in response to WPV1 outbreaks but these 
campaigns were implemented with monovalent 
OPV type 1. 
Response to the epidemic 
From the notification of  the first case of  WPV3 in 
Côte d'Ivoire in 2011, the Ministry of  Health and its 
partners (WHO, UNICEF…) tried to implement 
activities to control the polio epidemic but the 
ongoing political and military crisis hampered the 
implementation of  the activities. 
All the WPV3 cases of  2011 were investigated, but 
many of  these investigations were conducted late 
due to the crisis situation. 
During the year 2011, seven polio NIDs were 
organized in the country. The first campaign was 
th thimplemented from May 27  to May 30 , five months 
after the index case. 
The polio outbreak was interrupted in July as the 
date of  onset of  the last case was on 24 July 2011. 
This outbreak was interrupted after the two first 
campaigns. 
During the polio outbreak in 2011, the national EPI 
implemented activities to reinforce AFP surveillance 
in the country. 
511 AFP cases were reported in 2011, 36 of  them 
were WPV3 cases according to laboratory results. 
In response to the polio epidemic, the country 
carried out activities to strengthen routine EPI but 
the results were poor. At the end of  2011, the routine 
EPI coverage of  OPV3 was 58%. 
DISCUSSION
After more than 10 years without polio 
epidemic of  type 3 wild poliovirus, in 2011, Côte 
d'Ivoire faced an outbreak of  the wild poliovirus 
type 3. The median age of  WPV3 cases was two 
years old (interquartile range two to four years old). 
Thirty-five out of  36 polio cases were less than five 
Table V: Bivariate and Multivariate analysis of AFP cases (N=511)
Bivariate analysis Multivariate analysis
Variables  Categories  Odds Ratio  95% CI Odds Ratio  95% CI
Age Age 
< 5 years old
5.6  1.3 -  23.7 6.3 1.5 - 26.9





15.5 2.1 -114.5 16.9 2.3-125.0
Hospitalization Hospitalized 2.3 1.1 -  4.8
Fever Presence of 
fever





0.5  0.2 -  1.2
Asymmetrical Paralysis 
asymmetric
1.2  0.5 -  2.6
3 keys Polio signs
together Yes 1.3 0.5  3.1
Table VI: Evolution of the number of children not vaccinated per year
 in CI from 2006 to 2010





























76% 75% 58% 77%
Children not 
vaccinated  136080 149500 256620 143750
Total children Not vaccinated 
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years old. The results from our study are similar to a 
WHO statement indicating that polio mainly affects 
1children under 5 years old.  However, our 
observation differs from a study conducted in the 
Democratic Republic of  Congo (DRC) reporting 
that 58% of  34 cases of  WPV were over 15 years old. 
The ratio of  boys to girls was 1.6:1.0 which is almost 
similar to the epidemic in DRC where the sex ratio 
5
was 1.7.
Among the polio cases in the 2011 Côte d'Ivoire 
outbreak, most of  the subjects (75%) were living in 
rural areas and the majority of  them were living in 
precarious socio-economic conditions. A study in 
the Republic of  Congo also reported poor living 
6
conditions as risk factor of  polio epidemic.  
Regarding the number of  polio vaccine doses 
received by WPV3 cases in routine immunization, 29 
polio cases had less than 3 doses of  polio vaccines. 
According to CDC, more than 95% of  recipients 
1
seroconvert with 3 doses of  polio vaccine.  In 
Pointe-Noire (Republic of  Congo), a study found 
low vaccination coverage (55.5%) for polio cases. In 
Tajikistan, the main factor driving the development 
of  an outbreak was inadequate population immunity 
8
against poliovirus.  
Before the epidemic, WPV3 was circulating in the 
West African region particularly in Nigeria, Niger, 
Benin and Mali from 2008 to 2010. The circulation 
of  WPV3 in the region may have driven the outbreak 
as neighboring countries were in epidemic of  
WPV3. Genetic sequencing has enabled WHO to 
identify the WPV3 epidemic in Côte d'Ivoire as an 
importation of  WPV3 from Nigeria (11;12). 
Regarding acute flaccid paralysis surveillance, its 
objectives are to identify areas with WPV 
transmission and areas with low AFP reporting 
13
where polio cases might go undetected.  The AFP 
surveillance system in Côte d'Ivoire had poor 
indicators before the epidemic as reported in 2010. 
In that year, only 47% of  the districts reached the 
two major indicators of  AFP surveillance (rate of  
non-polio AFP and proportion of  stools collected in 
14 days). 
Thus, the country could have failed to detect the 
polio outbreak before 2011 as the surveillance 
indicators were weak. Even in 2011, from January to 
April, there were gaps in the AFP surveillance as the 
country was not able to strengthen its AFP 
surveillance during the conflict period. An analysis 
of  virus sequences done by the CDC provided 
evidence that AFP surveillance of  varying qualities 
had missed chains of  WPV transmission during 
13
2011 in Côte d'Ivoire.
The study on immunization status of  AFP cases in 
2011 showed that the median number of  doses was 
two (interquartile range zero to four doses). Among 
AFP cases, 71.2% received less than three doses of  
polio vaccine. In a study in China, out of  the 578 
AFP cases reported in 2011 in the region of  
Xinjiang, only 127 (22%) had received 3 doses or 
15
more OPV.  The number of  vaccine doses received 
by AFP cases could be an important indicator of  
children immunization in countries.   
Comparing polio cases to non-polio AFP cases, 
94.4% of  polio cases were under 5 years old while 
75.2% of  the non-polio AFP cases were less than 5 
years old. After adjustment for vaccination status 
(adjusted OR 6.3; 95% CI: 1.5-26.9) polio cases were 
more likely to be under 5 years old than non-polio 
cases. These results are in line with WHO statements 
1
on age of  polio cases.
Regarding vaccination status, after adjustment for 
age, polio cases were more likely to have less than 
three polio vaccine doses compared to non-polio 
cases (adjusted OR 16.9; 95% CI: 2.3 - 125.0). In 
China, the non-polio cases received 3 doses or more 
15OPV than polio cases.  Also in Angola, case-
patients were more likely than control-subjects to be 
under-vaccinated with less than four routine doses 
of  oral poliovirus vaccine with an odds ratio of  4.1 
16(95% confidence interval 1.2–13.6).  A study in 
Nigeria on AFP cases, wild poliovirus was only 
detected in children not vaccinated or uncompleted 
17
vaccinated.  
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Although these children with non-polio AFP are not 
representative of  other children in the country, their 
vaccination status could reflect that polio cases were 
less vaccinated than other children. In addition, 
among the AFP cases who received 3 doses of  polio 
vaccine, many of  them were not protected against 
poliovirus type 2 and type 3 because they just 
received monovalent type 1 during Supplementary 
Immunization Activities (SIA).
Concerning polio immunization in Côte d'Ivoire 
from 2006 to 2010, there was an accumulated 
number of  807,930 children not vaccinated for 
OPV3; meaning that 27% of  the children, who were 
expected to be vaccinated in that period, were not 
vaccinated. A study in Angola showed weak routine 
vaccination coverage (from 46% in 2005 to 75% in 
2008) before the onset of  epidemics in 2007 and 
16
2008.  In another study on a massive polio outbreak 
caused by type 3 wild poliovirus in Angola in 1999, 
low routine OPV coverage (45% in 1998) was found 
to be a major factor that contributed to this 
18
outbreak.  
Over several years, the routine immunization 
coverage in Côte d'Ivoire was less than the minimum 
cove r ag e  admi t t ed  by  WHO in  rou t ine 
immunization which is 80%. The data on OPV 
coverage in Côte d'Ivoire in this study are based on 
administrative coverage of  the country. The number 
of  non-vaccinated children could be even higher if  
this analysis was based on the coverage obtained 
during the evaluation of  the national EPI in 2010 
where OPV3 coverage was found to be 57%. 
In the period before the outbreak in Côte d'Ivoire in 
2011, there were several immunization campaigns 
against WPV1 epidemics. The vaccine used during 
these SIAs was the monovalent polio vaccine type 1 
(mOPV1) as monovalent OPV is more effective 
19than trivalent OPV to produce immunity  and there 
were several WPV1 outbreaks before 2011. Children 
non-immunized by trivalent routine vaccine could 
be protected by the campaigns. Unfortunately, the 
NIDs were implemented with monovalent type 1 
only. 
These children were therefore susceptible to wild 
poliovirus type 2 and type 3. In India, SIA rounds 
were conducted each year from 2007 to 2009 with 
tOPV, mOPV1 or mOPV3 in different areas 
20
depending on serotype specific assessment.  The 
introduction of  bivalent OPV 1& 3 reduced by 95% 
the number of  polio cases in 2010 compared to 
212009.  These studies show that the type of  polio 
vaccine used in polio SIAs is an important element in 
the eradication of  polio.  
We think that factors that could have led to this 
outbreak after importation of  WPV3 include the 
low coverage of  OPV of  routine immunization, 
vaccination during polio SIAs with monovalent type 
1 and precarious socio-economic conditions of  the 
population.
According to Patriarca PA, the most common cause 
for the persistence of  poliomyelitis in developing 
countries has been the failure of  routine 
immunization programs to provide three or more 
doses of  poliovirus vaccine to a high proportion of  
22
children.
Following this outbreak of  wild poliovirus type 3 in 
Côte d'Ivoire, the Ministry of  Health and its partners 
(WHO, UNICEF ...), implemented activities to 
interrupt polio transmission in the country. 
However, the investigation of  WPV3 cases was 
delayed. The first SIAs against the polio outbreak 
was held five months after the date of  onset of  the 
outbreak index case. Epidemiological surveillance 
was strengthened only five months after the index 
case was found. 
The delay in the response to the outbreak could be 
linked to the 2010 Côte d'Ivoire post-election crisis. 
Polio epidemic control can be very challenging in 
conflict environment. For instance in Afghanistan 
and Pakistan, WPV circulation in high-risk districts 
continued because of  difficulties of  reaching 
children in conflict-affected areas and operational 
23
limitations in parts of  Pakistan.  There were several 
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similar situations where conflicts affected polio 
eradication process like in Syria, Sudan and 
24
Colombia.  
The 2011 Côte d'Ivoire WVP3 epidemic was 
stopped after two response campaigns with bivalent 
OPV type 1 and type 3. Four polio NIDs were held 
after the last case in 2011 although the GPEI 
recommends only 2 NIDs after the last WPV case. 
In DRC, in the epidemic of  Kinshasa, several polio 
5
NIDs were held after the last polio case.
Although the epidemic was stopped in July 2011, we 
think that the delay in implementation of  response 
activities has been a factor in the spread of  the 
epidemic across the country and in the neighboring 
countries such as Mali and Guinea Conakry. 
According to GPEI, the time taken to detect and 
respond to an outbreak has been shown to be one of  
the most critical factors in limiting the size of  an 
25outbreak.  In a study, using mathematic modeling to 
evaluate the response scenarios to potential polio 
outbreaks, Thomson found that delay in response 
represents a crucial risk factor for occurrence of  
26
large outbreaks.  
This study has several limitations as the study design 
was retrospective, using AFP surveillance routine 
data, WPV3 investigation data and routine 
immunization data. The data on WPV3 were 
collected for the purpose of  epidemic investigation 
and the available data are only on polio cases (case 
series).
It was difficult in this study to make some 
comparisons as it was not set up to include a control 
group. The data of  AFP cases, there was a 
comparison group (non-polio AFP cases) but this 
group is not representative of  the general 
population. 
CONCLUSION 
Overall, this study shows that AFP surveillance was 
poorly performed before the 2011 Côte d'Ivoire 
WPV3 epidemic, and that 81% of  the polio cases 
had not been vaccinated. A large majority of  polio 
cases were living in precarious socio-economic 
conditions. There were an accumulated number of  
807,930 non-vaccinated children against polio. This 
means that more than 27% of  children were not 
vacc inated for  t r iva lent  OPV in rout ine 
immunization. Children were vaccinated with 
monovalent type 1 during polio SIAs. Finally WPV3 
was circulating in neighboring countries of  Côte 
d'Ivoire since 2008 (Genetic sequencing showed that 
the first cases were imported from Nigeria). All these 
factors could have contributed to the epidemic of  
WPV3. These factors are some of  the risk factors 
25
GPEI found to be contributing to polio outbreak.   
Despite the limitations, this study shows that a 
country which interrupted polio transmission for 
one type of  poliovirus can still be at high risk for 
polio outbreaks of  this same type following an 
importation when routine immunization coverage is 
low, polio supplementary immunization activities is 
done with only the poliovirus vaccine against the 
circulating poliovirus, people live in precarious 
socio-economic conditions and AFP surveillance is 
poorly performed. Côte d'Ivoire experienced this 
outbreak as many of  these conditions occurred 
together.  
The delay in the response to this outbreak may have 
contributed to the spread of  the disease in the whole 
country and in neighboring countries. The response 
activities to the epidemic were not carried out in 
time. In Côte d'Ivoire, this delay was partly due to a 
conflict environment. 
This outbreak emphasizes the necessity to reach and 
maintain high immunization coverage to prevent 
polio outbreaks, to select the appropriate polio 
vaccine combination during polio SIAs, to design an 
emergency plan particularly in countries at risk of  
conflict and to maintain high quality AFP 
surveillance to quickly identify and respond to any 
potential cases of  polio before an outbreak 
intensifies.
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ANNEXES:
Table IX :  Number of polio cases in western Africa from 2008 to 2011











Benin*  6 20
Burkina Faso  6 15
Cape Verde  0 0  
Côte d'Ivoire* 1 26
Gambia  0 0  
Ghana  8 0  
Guinea*  0 42
Guinea-Bissau 0 0  
Liberia 0 11
Mali*  1 2  
Mauritania  0 13
Niger*  12 15
Nigeria*  798 388
Sao Tome and 
Principe
0 0  
Senegal  0 0  
Sierra Leone  0 11
Togo  3 6  
















































Tables VII: Population characteristics in CI (Source: NIS)
Indicators  Values  Years  and  source*
Birth rate  35,7 per 1000 2011 (NIS)
Crude mortality rate  12,9 per 1000 2011 (NIS)
Life expectancy at birth 53,1 years 2011 (NIS)
Average annual 
population growth
2,6%  2011 (NIS)
Fertility rate  4,8 children per woman 2011 (NIS)
Proportion of people living
in poverty
 
48.9  2011 
Human development index 0.43  2011 
 
Figure 2:Evolution of WPV cases in Côte d’Ivoire from 1997 to 2010
 
Table VIII: polio NIDs in Côte d’Ivoire in 2009 and 2010 
(source National EPI database)
Years  2009  2010
Total Number of Polio NIDs  7 3  
Number of Polio NIDs with Monovalent type 1 7 3  
Number of Polio NIDs with Monovalent type 3 0 0  
Number of Polio NIDs with Trivalent 0 0  































































Geographic distribution wild poliovirus cases in Côte d'Ivoire in 
2011 (*number represent the sequences of cases occurrence). 
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